gilead sciences inc (GILD:NASDAQ GS)
Andrew Cheng M.D., Ph.D.
Senior Vice President of Development Operations, Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dr. Andrew Cheng, MD, PhD serves as Senior Vice President of HIV Therapeutics at Gilead Sciences, Inc., a Bay Area-based biopharmaceutical company focused on developing innovative medications for life-threatening diseases such as HIV/AIDS, hepatitis, respiratory and cardiovascular disease, and cancer. Dr. Cheng has been Senior Vice President of Development Operations at Gilead Sciences Inc., since January 2009. Dr. Cheng is responsible for Gilead's biometrics, clinical ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*
University of California-Los Angeles
Johns Hopkins University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$863.9K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Foster City, CA | Gilead SciencesPosted: Feb 22
- Foster City, CA | Gilead SciencesPosted: Jan 13
- California | Gilead Sciences (gilead Sciences)Posted: Feb 18
- California | Gilead SciencesPosted: Mar 11